Healthy Skepticism Library item: 5171

Warning: This library includes all items relevant to health product marketing that we are aware of regardless of quality. Often we do not agree with all or part of the contents.

Publication type: Journal Article

Medawar C.
Drug information.
Lancet 1993 Dec 11; 342:(8885):1490-1

Abstract:

There is also a concern that both the United States and the United Kingdom data sheets tend to be much more informative than manufacturers’ prescribing advice in countries where poverty and corruption are the norm. The pharmaceutical industry has usually explained its conduct by reference to variable regulatory requirements and differences in local medical practice but the real reason is a desire to maintain drug use. The UK data sheets may be so bad is that the responsibility for their production rests with bodies that are isolated from consumer views and fail to see the problem.

Keywords:
*letter to the editor/United Kingdom/developing countries/ data sheet & approved product information/ quality of information/EVALUATION OF PROMOTION: COMPARISON BETWEEN DEVELOPING AND DEVELOPED COUNTRIES/INFORMATION FROM INDUSTRY: DOCTORS

Notes:

Reply to: Tom Bell, Lancet 1993;342:1118.